These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2237137)

  • 21. Tetanus in Israel, Judea/Samaria and Gaza, 1968-89: progress and challenge.
    Tulchinsky TH; Friedman JB; Acker C; Ben David A; Slater PE
    Isr J Med Sci; 1990 Aug; 26(8):438-42. PubMed ID: 2401606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of the current impact of measles in the People's Republic of China.
    Zhang Y; Su W
    Rev Infect Dis; 1983; 5(3):411-6. PubMed ID: 6878991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poliomyelitis control in Israel, the West Bank and Gaza Strip: changing strategies with the goal of eradication in an endemic area.
    Goldblum N; Gerichter CB; Tulchinsky TH; Melnick JL
    Bull World Health Organ; 1994; 72(5):783-96. PubMed ID: 7955030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Optimal age for vaccination against measles].
    José MV; Kumate J
    Salud Publica Mex; 1989; 31(5):645-57. PubMed ID: 2692194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful control and impending elimination of measles in the Islamic Republic of Iran.
    Zahraei SM; Gouya MM; Azad TM; Soltanshahi R; Sabouri A; Naouri B; Alexander JP
    J Infect Dis; 2011 Jul; 204 Suppl 1():S305-11. PubMed ID: 21666178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing epidemiology of measles in Hong Kong from 1961 to 1990--impact of a measles vaccination program.
    Lau YL; Chow CB; Leung TH
    J Infect Dis; 1992 Jun; 165(6):1111-5. PubMed ID: 1583329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options.
    Babad HR; Nokes DJ; Gay NJ; Miller E; Morgan-Capner P; Anderson RM
    Epidemiol Infect; 1995 Apr; 114(2):319-44. PubMed ID: 7705494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The status of measles after five years of mass vaccination in the USSR.
    Burgasov PN; Andzaparidze OG; Popov VF
    Bull World Health Organ; 1973; 49(6):571-6. PubMed ID: 4548384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humoral and cellular immune response after measles vaccination in Taiwan.
    Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
    J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles, killer of millions in developing countries: strategy for rapid elimination and continuing control.
    Sabin AB
    Eur J Epidemiol; 1991 Jan; 7(1):1-22. PubMed ID: 1902797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Age-dependence of measles immunization failures].
    Giesecke H; Brendel P; Schmidt J; Schlenk B
    Z Gesamte Hyg; 1980; 26(10):764-67. PubMed ID: 7467503
    [No Abstract]   [Full Text] [Related]  

  • 33. Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months.
    Cutts FT; Monteiro O; Tabard P; Cliff J
    Bull World Health Organ; 1994; 72(2):227-31. PubMed ID: 8205642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measles epidemic in Israel-successful containment in the military.
    Gdalevich M; Ephros M; Mimouni D; Grotto I; Shpilberg O; Eldad A; Ashkenazi I
    Prev Med; 2000 Dec; 31(6):649-51. PubMed ID: 11133330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles epidemiology and outbreak response immunization in a rural community in Peru.
    Sniadack DH; Moscoso B; Aguilar R; Heath J; Bellini W; Chiu MC
    Bull World Health Organ; 1999; 77(7):545-52. PubMed ID: 10444877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles immunization: early two-doses policy experience.
    al-Mazrou YY; al-Jeffri M; Ahmed OM; Aziz KM; Mishkas AH
    J Trop Pediatr; 1999 Apr; 45(2):98-104. PubMed ID: 10341504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Various regularities of measles epidemic process during a period of mass vaccination of children].
    Schwars SA; Bukova VE
    Vopr Virusol; 1976; (4):420-5. PubMed ID: 137586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measles in Jordan: a prototype of the problems with measles in developing countries.
    Khuri-Bulos NA
    Pediatr Infect Dis J; 1995 Jan; 14(1):22-6. PubMed ID: 7715984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Alterations in epidemics and vaccination for measles during a 20 year period and a strategy for elimination in Kurashiki City, Japan].
    Terada K; Niizuma T; Ogita S; Kataoka N
    Kansenshogaku Zasshi; 2002 Mar; 76(3):180-4. PubMed ID: 11974886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
    Markowitz LE; Sepulveda J; Diaz-Ortega JL; Valdespino JL; Albrecht P; Zell ER; Stewart J; Zarate ML; Bernier RH
    N Engl J Med; 1990 Mar; 322(9):580-7. PubMed ID: 2304505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.